CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 14 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,743 | -31.9% | 26,529 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $34,886 | -17.3% | 26,529 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $42,181 | -74.5% | 26,529 | -48.6% | 0.00% | -75.0% |
| Q4 2022 | $165,146 | +77.6% | 51,608 | +38.1% | 0.00% | +100.0% |
| Q3 2022 | $93,000 | -39.2% | 37,371 | -9.5% | 0.00% | -50.0% |
| Q2 2022 | $153,000 | -22.7% | 41,300 | +0.0% | 0.00% | -20.0% |
| Q1 2022 | $198,000 | 0.0% | 41,298 | +44.1% | 0.01% | 0.0% |
| Q4 2021 | $198,000 | -58.9% | 28,653 | -34.1% | 0.01% | -61.5% |
| Q3 2021 | $482,000 | -53.7% | 43,459 | -20.6% | 0.01% | -60.6% |
| Q2 2021 | $1,041,000 | -41.3% | 54,729 | -11.4% | 0.03% | -50.0% |
| Q1 2021 | $1,773,000 | – | 61,761 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,578,174 | $12,375,000 | 0.20% |
| Ikarian Capital, LLC | 268,104 | $1,292,000 | 0.17% |
| Cormorant Asset Management, LP | 288,168 | $1,383,000 | 0.11% |
| BOOTHBAY FUND MANAGEMENT, LLC | 41,298 | $198,000 | 0.01% |
| MEITAV INVESTMENT HOUSE LTD | 35,024 | $167,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,100 | $5,000 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 10,807 | $52,000 | 0.00% |
| JPMORGAN CHASE & CO | 753 | $4,000 | 0.00% |
| Renaissance Technologies | 27,960 | $134,000 | 0.00% |
| ARK Investment Management | 792 | $4,000 | 0.00% |